Brown News. The new center will focus on the early detection and treatment of Alzheimer’s Disease, drawing together research scientists and physicians from Brown’s Division of Biology and Medicine and the Carney Institute for Brain Science. One of the early goals of the center is to establish a biomarker facility dedicated to collecting patient samples to identify disease biomarkers and test treatment efficacy.

By fostering collaboration, the new research center will augment Brown’s existing strength in neuroscience and neurodegenerative research. The Brown Technology Innovations office continues to support new neuroscience startups and partnerships, including Bolden Therapeutics and BridgeBio.

Brown neuroscience researchers interested in exploring commercial applications of their work can start the disclosure process or email us at tech-innovations@brown.edu.